Iambic Therapeutics
127 employees
Biotech/Pharma
Series C · $306.0M
Open positions (16)
Company details
Team Size127
IndustryBiotech/Pharma
Funding
Total raised
$306.0M
Last stage
Series C
Investors
Total raised
$306.0M
Last stage
Series C
Investors
Thomas Miller
Scientist and entrepreneur focused on the nexus of AI, chemistry, and biology. Former Caltech professor. Co-founded Iambic (formerly Entos) to apply AI-driven drug discovery.
LinkedInFred Manby
PhD/DPhil in theoretical chemistry, formerly a professor at the University of Bristol. Co-founded Iambic with Thomas Miller to build AI-driven drug discovery platform.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.